Results 221 to 230 of about 171,175 (241)

A splice-switching antisense oligonucleotide approach for pediatric genetic epilepsies

Dame HB, Kopalle H, Miñana B, Klaft Z, Fahey JB, McWatters DC, Rao V, Suresh R, Aigner S, Hammer MF, Yuskaitis CJ, Wong M, Teaney N, Zhang C, Thompson M, Lehner B, Bennett CF, Valcárcel J, Yeo GW, Burge CB, Dulla CG, Oudin MJ.   +21 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations

Molecular Therapy, 2021
Ronald J E Pennings, Peter Adamson, Theo Peters   +2 more
exaly  

An antisense oligonucleotide to target the RAAS

Nature Reviews Cardiology, 2021
Irene Fernández-Ruiz
exaly  

Counteracting chromatin effects of a splicing-correcting antisense oligonucleotide improves its therapeutic efficacy in spinal muscular atrophy

Cell, 2022
Tomoki Nomakuchi, Nicholas Jarvis Proudfoot, Adrian Robert Krainer   +2 more
exaly  

Base-modified aptamers obtained by cell-internalization SELEX facilitate cellular uptake of an antisense oligonucleotide

Molecular Therapy - Nucleic Acids, 2021
Yuuya Kasahara, Takumi Okuda, Satoshi Obika   +2 more
exaly  

Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect

Nature Medicine, 2018
Michael E. Cheetham, Alejandro J Roman, Caroline Van Cauwenbergh   +2 more
exaly  

NMDA-R1 antisense oligonucleotide attenuates withdrawal signs from morphine

European Journal of Pharmacology, 1998
Kang Ho, I K Ho
exaly  

2′-Carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation

Biochimica Et Biophysica Acta Gene Regulatory Mechanisms, 1999
Muthiah Manoharan
exaly  

Delivery of antisense oligonucleotide using polyethylenimine-based lipid nanoparticle modified with cell penetrating peptide

Drug Delivery, 2019
Yaojun Sun
exaly